A self‐locking MN patch for psoriasis delivers TYK2 inhibitor to target skin‐originated inflammation and modulate local immune microenvironment, while simultaneously releases Cal for sustained anti‐proliferative effects on persistent hyperproliferative lesions. The gene discussed is TYK2; the disease is psoriasis.